French biotech Horama has treated the first patients with a gene therapy for retinitis pigmentosa that could prevent the progressive loss of vision caused by this genetic condition. A Phase I/II trial with Horama’s gene therapy for retinitis pigmentosa is running ...
The post Gene Therapy for Retinitis Pigmentosa Tested in Humans for the First Time appeared first on Labiotech.eu.